14 research outputs found
Long-term safety and efficacy of bisphosphonate (BP) therapy for more than 24 months (M) in breast cancer (BC) patients (pts) with bone metastasis (BM)
No full textRandomized phase II study of epirubicin (E) plus cyclophosphamide (C) vs. weekly paclitaxel (P) as primary systemic therapy (PST) in patients (pts) with stage II and III breast cancer (BC)
No full textInduction of primary systemic therapy by weekly paclitaxel: Predictive value of hormone receptors, HER-2, topoisomerase II- alpha, and other biological markers in relation to pathological complete response
No full textRandomized phase II clinical trial of comparison of epirubicin (E) plus cyclophosphamide (C) and weekly paclitaxel (P) as primary systemic therapy (PST) in patients (pts) with stages II and III breast cancer (BC)
No full textPhase Transition in Polyelectrolyte Hydrogels Driven by Formation and Destruction of Hydrogen Bonds
No full textPurification and characterization of a macromolecular-translocation inhibitor III of activated glucocorticoid-receptor-complex binding to nuclei from rat liver
No full textEarly gastric cancer with suspected brain metastasis arising eight years after curative resection: a case report
No full textClinicopathological characteristics of non palpable breast cancer presenting as an axillary Mass
No full textSelection process for botulinum toxin injections in patients with chronic-stage hemiplegic stroke: a qualitative study
No full text
